Design, Synthesis and Biological Evaluation of Salicylamide Analogues as Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
作者:Yang Liu、Yijing Li、Jianzhen Liu、Limin Yang、Pengzhan Li、Guisen Zhao
DOI:10.2174/1570180812666150819003111
日期:2016.3.3
Blocking epidermal growth factor receptor (EGFR) has been the hotspot in the field of cancer therapy. Based on the fact that salicylanilides possess well inhibitory activity against EGFR tyrosine kinase, a series of salicylamide analogs bearing 4’-substitution were designed to explore new candidates exhibiting improved efficacy against EGFR. Many of the synthesized compounds inhibited EGFR in the micromolar
阻断表皮生长因子受体(EGFR)已成为癌症治疗领域的热点。基于水杨酰苯胺对EGFR酪氨酸激酶具有良好的抑制活性这一事实,设计了一系列带有4'取代的水杨酰胺类似物,以探索对EGFR表现出更高疗效的新候选药物。许多合成的化合物在微摩尔范围内抑制EGFR,尤其是化合物15a和15b(IC 50分别为0.27μM和1.1μM)。我们报告我们的发现,作为进一步发展作为EGFR抑制剂的水杨酰胺类似物的基础。